S

Savara
D

SVRA

5.10000
USD
-0.20
(-3.77%)
مغلق
حجم التداول
36,029
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
1,045,128,781
أصول ذات صلة المقالات
المزيد

العنوان: Savara

القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).